• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: effects on activity level in the classroom and on the playground.

作者信息

Swanson James M, Gupta Suneel, Williams Lillie, Agler Dave, Lerner Marc, Wigal Sharon

机构信息

Child Development Center, University of California, Irvine, CA, USA.

出版信息

J Am Acad Child Adolesc Psychiatry. 2002 Nov;41(11):1306-14. doi: 10.1097/00004583-200211000-00011.

DOI:10.1097/00004583-200211000-00011
PMID:12410072
Abstract

OBJECTIVES

To evaluate the pharmacodynamic effects of an experimental (EXP) delivery of methylphenidate (MPH) in children with attention-deficit/hyperactivity disorder and to investigate the situational nature of effects in laboratory classroom and playground settings.

METHOD

A "sipping" study methodology was used to deliver a bolus followed by small but increasing MPH doses as the EXP regimen. A randomized, double-blind crossover design was used to compare the EXP regimen to a thrice-daily (TID) regimen and a placebo (PLA) regimen. Measures of efficacy were obtained from a Motionlogger actigraph to quantify activity and from the Swanson, Kotkin, Agler, M-Flynn, and Pelham (SKAMP) rating scale to quantify two domains of behavior (attention and deportment).

RESULTS

Compared with PLA, both EXP and TID delivery of MPH produced large, significant reductions in activity and inappropriate behavior in the classroom, but the two MPH regimens did not differ in onset or duration of effects across the day. The MPH effects were situationally dependent and were smaller for the playground than for the classroom settings.

CONCLUSIONS

The findings of this "proof of concept" study support the efficacy of a continuous, ascending delivery of MPH. The situational effects of MPH provide support for the theory of selective effects of stimulants, dependent on the demands of the environment.

摘要

相似文献

1
Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: effects on activity level in the classroom and on the playground.
J Am Acad Child Adolesc Psychiatry. 2002 Nov;41(11):1306-14. doi: 10.1097/00004583-200211000-00011.
2
A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).实验室学校中患有注意力缺陷/多动障碍儿童使用每日一次缓释哌甲酯制剂的比较(Comacs研究)
Pediatrics. 2004 Mar;113(3 Pt 1):e206-16. doi: 10.1542/peds.113.3.e206.
3
Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder.不同早餐条件下,哌甲酯控释片在注意缺陷多动障碍患儿中的药代动力学及治疗效果
J Child Adolesc Psychopharmacol. 2011 Jun;21(3):255-63. doi: 10.1089/cap.2010.0083.
4
Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.在实验室课堂环境中,针对6至12岁患有注意力缺陷/多动障碍儿童的缓释口服崩解型哌甲酯片的疗效、安全性及耐受性研究
J Child Adolesc Psychopharmacol. 2017 Feb;27(1):66-74. doi: 10.1089/cap.2016.0002. Epub 2016 May 16.
5
Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder.缓释右美沙芬与安慰剂治疗注意缺陷多动障碍学龄儿童的疗效及作用持续时间
J Child Adolesc Psychopharmacol. 2006 Jun;16(3):239-51. doi: 10.1089/cap.2006.16.239.
6
Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.每日一次服用的盐酸哌甲酯控释片与每日三次服用的哌甲酯在实验室及自然环境中的对比研究。
Pediatrics. 2001 Jun;107(6):E105. doi: 10.1542/peds.107.6.e105.
7
Efficacy and safety of extended-release dexmethylphenidate compared with d,l-methylphenidate and placebo in the treatment of children with attention-deficit/hyperactivity disorder: a 12-hour laboratory classroom study.右旋甲基苯丙胺缓释剂与消旋甲基苯丙胺及安慰剂治疗儿童注意力缺陷/多动障碍的疗效和安全性:一项12小时实验室课堂研究
J Child Adolesc Psychopharmacol. 2008 Jun;18(3):248-56. doi: 10.1089/cap.2007.0015.
8
Treatment of children with attention-deficit/hyperactivity disorder: results of a randomized, multicenter, double-blind, crossover study of extended-release dexmethylphenidate and D,L-methylphenidate and placebo in a laboratory classroom setting.注意缺陷多动障碍儿童的治疗:在实验室教室环境中进行的右旋哌甲酯控释片、消旋甲基苯丙胺和安慰剂的随机、多中心、双盲、交叉研究结果
Psychopharmacol Bull. 2008;41(1):19-33.
9
A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.一项随机、安慰剂对照、双盲研究,评估盐酸哌甲酯缓释胶囊治疗注意缺陷/多动障碍儿童的反应时间过程。
J Child Adolesc Psychopharmacol. 2014 Dec;24(10):562-9. doi: 10.1089/cap.2014.0100.
10
Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder.右旋哌甲酯缓释胶囊用于治疗注意缺陷多动障碍儿童。
J Am Acad Child Adolesc Psychiatry. 2008 Feb;47(2):199-208. doi: 10.1097/chi.0b013e31815cd9a4.

引用本文的文献

1
A framework for remotely enabled co-design with young people: its development and application with neurodiverse children and their caregivers.一个与年轻人进行远程协同设计的框架:其针对神经发育障碍儿童及其照顾者的开发与应用。
Front Psychiatry. 2024 Aug 16;15:1432620. doi: 10.3389/fpsyt.2024.1432620. eCollection 2024.
2
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
3
Time-varying SUVr reflects the dynamics of dopamine increases during methylphenidate challenges in humans.
时间变化的 SUVr 反映了人类在哌甲酯挑战期间多巴胺增加的动态。
Commun Biol. 2023 Feb 10;6(1):166. doi: 10.1038/s42003-023-04545-3.
4
Inducing a Functional-Pharmacological Coupling in the Human Brain to Achieve Improved Drug Effect.在人脑中诱导功能-药理偶联以实现增强的药物效果。
Front Neurosci. 2020 Oct 9;14:557874. doi: 10.3389/fnins.2020.557874. eCollection 2020.
5
A Review of the Clinical Utility of Systematic Behavioral Observations in Attention Deficit Hyperactivity Disorder (ADHD).注意缺陷多动障碍(ADHD)中系统行为观察的临床效用综述
Child Psychiatry Hum Dev. 2018 Aug;49(4):572-606. doi: 10.1007/s10578-017-0776-2.
6
Effects of maternal symptom ratings and other clinical features on short-term treatment response to OROS methylphenidate in children and adolescents with ADHD in a naturalistic clinical setting.在自然临床环境中,母亲症状评分及其他临床特征对多动症儿童和青少年使用奥氮平控释片短期治疗反应的影响。
Klinik Psikofarmakol Bulteni. 2016;26(2):126-133. doi: 10.5455/bcp.20150703013708.
7
Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in Adults.基于生理的吸收模型在表征成人口服缓释哌醋甲酯产品药代动力学特征中的应用。
PLoS One. 2016 Oct 10;11(10):e0164641. doi: 10.1371/journal.pone.0164641. eCollection 2016.
8
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
9
Association Between 5-HTTLPR Polymorphism and Tics after Treatment with Methylphenidate in Korean Children with Attention-Deficit/Hyperactivity Disorder.韩国注意缺陷多动障碍儿童使用哌甲酯治疗后5-羟色胺转运体基因启动子区域多态性(5-HTTLPR)与抽动之间的关联
J Child Adolesc Psychopharmacol. 2015 Oct;25(8):633-40. doi: 10.1089/cap.2014.0168. Epub 2015 Sep 24.
10
Neuropharmacological effect of methylphenidate on attention network in children with attention deficit hyperactivity disorder during oddball paradigms as assessed using functional near-infrared spectroscopy.哌醋甲酯对注意缺陷多动障碍儿童在奇异性范式下注意网络的神经药理学作用:使用功能近红外光谱评估。
Neurophotonics. 2014 Jul;1(1):015001. doi: 10.1117/1.NPh.1.1.015001. Epub 2014 May 28.